ArticleJournal for immunotherapy of cancer2025

Enabling access to genetically modified cell therapies through flexible approaches to manufacturing and cost recovery.

Mark D Stewart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.